These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 15780731

  • 1. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL, Holzmuller P, Cavaleyra M, Gonçalves RB, Hottin G, Papierok G.
    Vaccine; 2005 Apr 22; 23(22):2825-40. PubMed ID: 15780731
    [Abstract] [Full Text] [Related]

  • 2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
    Daneshvar H, Molaei MM, Kamiabi H, Burchmore R, Hagan P, Stephen Phillips R.
    Parasite Immunol; 2010 May 22; 32(11-12):722-30. PubMed ID: 21039612
    [Abstract] [Full Text] [Related]

  • 8. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
    Gradoni L, Foglia Manzillo V, Pagano A, Piantedosi D, De Luna R, Gramiccia M, Scalone A, Di Muccio T, Oliva G.
    Vaccine; 2005 Nov 01; 23(45):5245-51. PubMed ID: 16054272
    [Abstract] [Full Text] [Related]

  • 9. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I, Alonso A, Marcen JM, Peris A, Castillo JA, Colmenares M, Larraga V.
    Vaccine; 2008 Jan 17; 26(3):333-44. PubMed ID: 18093705
    [Abstract] [Full Text] [Related]

  • 10. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E, Pagniez J, Papierok G, Vincendeau P, Lemesre JL, Bras-Gonçalves R.
    PLoS Negl Trop Dis; 2016 May 17; 10(5):e0004614. PubMed ID: 27223609
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.
    Saldarriaga OA, Travi BL, Park W, Perez LE, Melby PC.
    Vaccine; 2006 Mar 10; 24(11):1928-40. PubMed ID: 16310897
    [Abstract] [Full Text] [Related]

  • 12. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R, Santarém N, Cunha J, Cardoso L, Nieto J, Carrillo E, Moreno J, Cordeiro-da-Silva A.
    Vet Parasitol; 2008 Nov 25; 158(1-2):23-30. PubMed ID: 18848397
    [Abstract] [Full Text] [Related]

  • 13. Canine Leishmania vaccines: still a long way to go.
    Gradoni L.
    Vet Parasitol; 2015 Feb 28; 208(1-2):94-100. PubMed ID: 25620293
    [Abstract] [Full Text] [Related]

  • 14. Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs.
    Daneshvar H, Molaei MM, Afshar RM, Kamiabi H, Burchmore R, Hagan P, Phillips RS.
    Vet Immunol Immunopathol; 2009 May 15; 129(1-2):28-35. PubMed ID: 19147233
    [Abstract] [Full Text] [Related]

  • 15. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.
    Poot J, Janssen LH, van Kasteren-Westerneng TJ, van der Heijden-Liefkens KH, Schijns VE, Heckeroth A.
    Vaccine; 2009 Jul 16; 27(33):4439-46. PubMed ID: 19500553
    [Abstract] [Full Text] [Related]

  • 16. Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.
    Rafati S, Nakhaee A, Taheri T, Taslimi Y, Darabi H, Eravani D, Sanos S, Kaye P, Taghikhani M, Jamshidi S, Rad MA.
    Vaccine; 2005 May 25; 23(28):3716-25. PubMed ID: 15882533
    [Abstract] [Full Text] [Related]

  • 17. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs.
    Poot J, Rogers ME, Bates PA, Vermeulen A.
    Vet Parasitol; 2005 Jun 10; 130(1-2):41-53. PubMed ID: 15893068
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D, Baneth G, Shor S, Okano F, Jaffe CL.
    Int J Parasitol; 2005 Jan 10; 35(1):63-73. PubMed ID: 15619517
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.
    Fujiwara RT, Vale AM, França da Silva JC, da Costa RT, Quetz Jda S, Martins Filho OA, Reis AB, Corrêa Oliveira R, Machado-Coelho GL, Bueno LL, Bethony JM, Frank G, Nascimento E, Genaro O, Mayrink W, Reed S, Campos-Neto A.
    Vet Res; 2005 Jan 10; 36(5-6):827-38. PubMed ID: 16120256
    [Abstract] [Full Text] [Related]

  • 20. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers.
    Carrera L, Fermín ML, Tesouro M, García P, Rollán E, González JL, Méndez S, Cuquerella M, Alunda JM.
    Exp Parasitol; 1996 Mar 10; 82(2):139-46. PubMed ID: 8617340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.